Expression of CD27-CD70 on early B cell progenitors in the bone marrow:: Implication for diagnosis and therapy of childhood ALL

被引:48
作者
Nilsson, A [1 ]
de Milito, A
Mowafi, F
Winberg, G
Björk, O
Wolpert, EZ
Chiodi, F
机构
[1] Astrid Lindgren Children Hosp, Pediat Canc Res Unit, S-17176 Stockholm, Sweden
[2] Karolinska Inst, Ctr Microbiol & Tumor Biol, Stockholm, Sweden
关键词
D O I
10.1016/j.exphem.2005.10.005
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective. CD27, a member of the TNF receptor family, plays an important role in lymphoid proliferation, differentiation and apoptosis. This study addresses the expression of CD27 and its ligand, CD70, in children with acute lymphoblastic leukemia (ALL) and the possible role of this receptor-ligand pair in the pathogenesis of ALL. Patients and Methods. Expression of CD27 and CD70 was evaluated with three-color flow cytometry in blood and bone marrow (BM) samples in children with ALL and controls. The biological role of these molecules on leukemic cell proliferation was studied in an in vitro culture system. Results. The expression of the membrane bound CD27, as well as membrane bound CD70, on CD19(+) cells in the BM was significantly increased in ALL children compared to the expression found in the controls. importantly, a substantial reduction in the in vitro proliferation of leukemic cells could be observed when the leukemic cells were cultured in presence of a blocking anti-human CD70 monoclonal antibody. The level of soluble CD27 (sCD27) in serum was also investigated and found to be significantly elevated in leukemic children as compared to healthy children. Conclusion. The high expression of CD27 and CD70 on ALL cells may represent an amplification of the normal CD27-CD70 expression present on early B cell progenitors. Our finding suggests that interference with CD27-CD70 interaction may represent novel treatment opportunities in ALL. Further studies are required to pin-point the role of this receptor-ligand pair in normal and malignant hematopoiesis. (c) 2005 International Society for Experimental Hematology. Published by Elsevier Inc.
引用
收藏
页码:1500 / 1507
页数:8
相关论文
共 33 条
[1]  
AGATHANGGELOU A, 1995, AM J PATHOL, V147, P1152
[2]   Generation of plasma cells from peripheral blood memory B cells: Synergistic effect of interleukin-10 and CD27/CD70 interaction [J].
Agematsu, K ;
Nagumo, H ;
Oguchi, Y ;
Nakazawa, T ;
Fukushima, K ;
Yasui, K ;
Ito, S ;
Kobata, T ;
Morimoto, C ;
Komiyama, A .
BLOOD, 1998, 91 (01) :173-180
[3]   B cell subpopulations separated by CD27 and crucial collaboration of CD27(+) B cells and helper T cells in immunoglobulin production [J].
Agematsu, K ;
Nagumo, H ;
Yang, FC ;
Nakazawa, T ;
Fukushima, K ;
Ito, S ;
Sugita, K ;
Mori, T ;
Kobata, T ;
Morimoto, C ;
Komiyama, A .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1997, 27 (08) :2073-2079
[4]   Spontaneous development of plasmacytoid tumors in mice with defective Fas-Fas ligand interactions [J].
Davidson, WF ;
Giese, T ;
Fredrickson, TN .
JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 187 (11) :1825-1838
[5]   Plasma levels of soluble CD27:: a simple marker to monitor immune activation during potent antiretroviral therapy in HIV-1-infected subjects [J].
De Milito, A ;
Aleman, S ;
Marenzi, R ;
Sönnerborg, A ;
Fuchs, D ;
Zazzi, M ;
Chiodi, F .
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2002, 127 (03) :486-494
[6]   The metalloproteinase inhibitor GI5402 inhibits endotoxin-induced soluble CD27 and CD16 release in healthy humans [J].
Dekkers, PEP ;
ten Hove, T ;
Lauw, FN ;
Koene, HR ;
Lumley, P ;
van Deventer, SJH ;
van der Poll, T .
INFECTION AND IMMUNITY, 2000, 68 (05) :3036-3039
[7]   Elevated soluble CD27 levels in serum of patients with systemic lupus erythematosus [J].
Font, J ;
Pallares, L ;
Martorell, J ;
Martinez, E ;
Gaya, A ;
Vives, J ;
Ingelmo, M .
CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1996, 81 (03) :239-243
[8]   Tumor necrosis factor receptor family members in the immune system [J].
Gravestein, LA ;
Borst, J .
SEMINARS IN IMMUNOLOGY, 1998, 10 (06) :423-434
[9]   Origins of chromosome translocations in childhood leukaemia [J].
Greaves, MF ;
Wiemels, J .
NATURE REVIEWS CANCER, 2003, 3 (09) :639-649
[10]   TUMOR-NECROSIS-FACTOR LIGAND SUPERFAMILY - INVOLVEMENT IN THE PATHOLOGY OF MALIGNANT-LYMPHOMAS [J].
GRUSS, HJ ;
DOWER, SK .
BLOOD, 1995, 85 (12) :3378-3404